Michele Korfin, RPh, MBA, has served Tyme's Chief Commercial Officer since October 2018 and assumed the role of Chief Operating Officer in March 2019. Michele has over 20 years of experience in oncology, focused on product launches, oncology marketing strategy, commercial sales, market access, and government affairs.

In this episode Michele covers some fascinating topics like:

The Hill, Congress, and the political side of a biotech company when it comes to patient advocacy.

Her previous experiences at Celgene, launching one of the leading cancer drugs.

Why Michele decided to join the Tyme team.

The FDA, and the regulatory environment and processes.

· Patients seeking therapy and how Tyme is working with top cancer centers around the country.

Please enjoy the show, and don't forget to rate, share, and review this podcast! We may be making forward looking statements, regarding our operational outlook, as well as our regulatory and product development plans. These statements are subject to risk and uncertainties that may cause actual results to differ from those forecasted. A description of those risks can be found in our most recent 10-K on file with the Securities and Exchange Commission.